StockData
Legend Biotech Corp logo

Legend Biotech Corp (LEGN) stock

LEGNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 10, 2026Score 3/30
$16.11+0.12 (+0.75%)

Close on Nov 17, 2026Market cap $2.98BP/E –Yield –

Legend Biotech total assets

Total assets on the balance sheet at the end of each period.

Legend Biotech's total assets was $1.75B at Jun 30, 2026. For fiscal 2025 it was $1.73B, up 3.8% from the year before. The highest annual figure on record is $1.85B in fiscal 2023.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.73B+3.8%
FY2024Dec 31, 2024$1.67B-9.7%
FY2023Dec 31, 2023$1.85B+38.9%
FY2022Dec 31, 2022$1.33B+18.9%
FY2021Dec 31, 2021$1.12B+55.0%
FY2020Dec 31, 2020$722.09M+146.8%
FY2019Dec 31, 2019$292.62M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$1.75B+3.6%
Q1 FY2026Mar 31, 2026$1.60B-1.2%
Q4 FY2025Dec 31, 2025$1.73B+3.8%
Q3 FY2025Sep 30, 2025$1.71B-1.3%
Q2 FY2025Jun 30, 2025$1.69B-6.0%
Q1 FY2025Mar 31, 2025$1.62B-9.0%
Q4 FY2024Dec 31, 2024$1.67B-9.7%
Q3 FY2024Sep 30, 2024$1.74B-5.6%
Q2 FY2024Jun 30, 2024$1.80B-6.9%
Q1 FY2024Mar 31, 2024$1.78B+33.4%
Q4 FY2023Dec 31, 2023$1.85B+65.1%
Q3 FY2023Sep 30, 2023$1.84B+110.2%
Q2 FY2023Jun 30, 2023$1.93B+167.4%
Q4 FY2022Dec 31, 2022$1.33B+354.8%
Q4 FY2021Dec 31, 2021$1.12B–
Q2 FY2021Jun 30, 2021$875.13M–
Q4 FY2020Dec 31, 2020$722.09M–
Q4 FY2019Dec 31, 2019$292.62M–

More Legend Biotech figures

See a number that looks wrong?